Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chaigui Longmu Ejiao Paste in Ischemic Heart Disease
NCT07478328Phase 2Not yet recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Chaigui Longmu Ejiao Paste in ischemic heart disease (IHD), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Chaigui Longmu Ejiao Paste
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT07478328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07478328.